Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by University of Alabama at Birmingham
Sponsor:
Collaborator:
Miltenyi Biotec, Inc.
Information provided by (Responsible Party):
Ayman Saad, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT00959140
First received: August 12, 2009
Last updated: June 27, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2018
  Estimated Primary Completion Date: October 2017 (Final data collection date for primary outcome measure)